No effect seen on mean frailty scores over time or rate of change in mean frailty score with supplementation
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Neither supplementation with vitamin D₃ nor omega-3 affect the rate of frailty change or incidence over time among older adults, according to a study published online Sept. 13 in JAMA Network Open.
Ariela R. Orkaby, M.D., M.P.H., from the Veterans Affairs Boston Healthcare System, and colleagues conducted a 2 x 2 factorial randomized trial to examine the effects of vitamin D₃ and omega-3 supplements on frailty among 25,871 individuals (men aged 50 years and older and women aged 55 years and older) without cancer or cardiovascular disease. Sufficient data to calculate a frailty index were available for 25,057 participants.
The mean frailty score was 0.109, and 12.7 percent of participants were frail. The researchers found that neither vitamin D₃ nor omega-3 supplementation affected mean frailty scores over time (mean difference at year 5: vitamin D₃, −0.0002; omega-3, −0.0001) or the rate of change in mean frailty score. Over time, incident frailty remained similar. Using the frailty physical phenotype, results were similar.
“These results do not support the routine use of either vitamin D₃ or omega-3 fatty acid supplementation for prevention of frailty in healthy, community-dwelling older adults,” the authors write.
Prep for Conservative Management, Dialysis Yield Similar Results in Older Patients With Kidney Failure 
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults 
Vitamin C Supplements in Pregnancy May Boost Infant Emotional Well-Being .jpg)
Recurrent Visual Field Progression Happens for 1 in 4 With Glaucoma 
Statin Use Linked to Lower Risk for Glaucoma Incidence 
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk 
Ambient Temperature Linked to Intraocular Pressure in Glaucoma 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
